BMCAX
Price
$23.90
Change
-$0.31 (-1.28%)
Updated
Jun 13 closing price
Net Assets
1.46B
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

BMCAX vs RGEBX

Header iconBMCAX vs RGEBX Comparison
Open Charts BMCAX vs RGEBXBanner chart's image
BlackRock Advantage Large Cap Gr Inv A
Price$23.90
Change-$0.31 (-1.28%)
VolumeN/A
Net Assets1.46B
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
BMCAX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BMCAX vs. RGEBX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMCAX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. BMCAX (1.46B). BMCAX (0.00) and RGEBX (0.00) have matching dividends . BMCAX was incepted earlier than RGEBX: BMCAX (39 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than BMCAX (1.01). BMCAX is a more actively managed with annual turnover of: 128.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than BMCAX: RGEBX (250) vs BMCAX (1000). RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. BMCAX (-6.42). RGEBX return over 5 years is better than : 45.42 vs. BMCAX (38.13).
BMCAXRGEBXBMCAX / RGEBX
Total Expense Ratio0.871.0980%
Annual Report Gross Expense Ratio1.011.0993%
Fund Existence39 years11 years-
Gain YTD2.0504.82942%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B306B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-6.427.68-84%
Returns for 3 years50.8451.01100%
Returns for 5 years38.1345.4284%
Returns for 10 years92.2965.87140%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd